Enasidenib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Enasidenib is used to treat acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation in patients who have not responded to other treatments or to those whose cancer has come back after treatment.Enasidenib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Enasidenib Nitroso Impurity 2 CAS NO: NA chemically represented as N-(4-((2-Hydroxy-2-methylpropyl)(nitroso)amino)-6-(6-(trifluoromethyl)pyridin-2-yl)-1,3,5-triazin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)nitrous amide. Synchemia is the leading manufacturing and exporter of Enasidenib Nitroso Impurity 2 . We supply Enasidenib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143060 |
| CAS No | NA |
| Mol.F. | C25H33F3N4O7 |
| Mol.Wt. | 558.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143061 |
| CAS No | NA |
| Mol.F. | C20H26F3N3O6 |
| Mol.Wt. | 461.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143062 |
| CAS No | NA |
| Mol.F. | C20H24F3N3O7 |
| Mol.Wt. | 475.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143063 |
| CAS No | NA |
| Mol.F. | C23H32N4O8 |
| Mol.Wt. | 492.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143064 |
| CAS No | NA |
| Mol.F. | C8H12ClN3O2 |
| Mol.Wt. | 217.65 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143065 |
| CAS No | NA |
| Mol.F. | C14H11N5O2 |
| Mol.Wt. | 281.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143066 |
| CAS No | NA |
| Mol.F. | C22H22ClN7O2 |
| Mol.Wt. | 451.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143067 |
| CAS No | NA |
| Mol.F. | C8H10ClN3O2 |
| Mol.Wt. | 215.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143068 |
| CAS No | NA |
| Mol.F. | C14H11N5O |
| Mol.Wt. | 265.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143069 |
| CAS No | NA |
| Mol.F. | C25H28ClN7O2 |
| Mol.Wt. | 494.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143070 |
| CAS No | NA |
| Mol.F. | C41H36ClN7O2 |
| Mol.Wt. | 694.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143071 |
| CAS No | NA |
| Mol.F. | C24H24ClN7O3 |
| Mol.Wt. | 493.95 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143072 |
| CAS No | NA |
| Mol.F. | C22H20ClN7O2 |
| Mol.Wt. | 449.90 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143073 |
| CAS No | NA |
| Mol.F. | C44H43Cl2N13O2 |
| Mol.Wt. | 856.82 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143074 |
| CAS No | NA |
| Mol.F. | C44H43Cl2N13O2 |
| Mol.Wt. | 856.82 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143075 |
| CAS No | NA |
| Mol.F. | C16H13N5O3 |
| Mol.Wt. | 323.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |